When a brand-name GLP-1 gets denied and stays denied, switching to a compounded version is often the fastest way to actually start treatment. It is not the same product and it is not insurance-covered, but it is available now, at a known monthly price, without another round of paperwork.
Switching is straightforward once you decide to do it. You complete an online visit, a licensed provider reviews your history, and if approved, your compounded semaglutide or tirzepatide ships from a partner pharmacy. There is no formulary to satisfy and no appeal to file first.
Start your intake →Why people switch after a denial
Most people do not start out wanting a compounded medication. They start out trying to get their plan to pay for a brand-name drug. The process either drags on for months or ends in a denial that will not budge on appeal, and at some point, waiting stops being the plan and becomes the problem.
Compounded treatment gets considered at that point not because it is a shortcut, but because it removes the one variable a patient cannot control: whether an insurance company decides to pay. A cash-pay option with a fixed monthly cost is a different kind of decision than a request sitting in a review queue.
It helps to be clear about what switching actually means. You are not obtaining the brand-name product through a workaround. You are choosing a different, compounded medication prepared by a licensed pharmacy, which is a distinct option with its own regulatory category.
What compounded actually means
Compounded medication is prepared by a licensed pharmacy to a formula, rather than manufactured as a mass-produced, FDA-approved product. It is legal and it is regulated, but it is not FDA-approved in the way a brand-name drug is, and that distinction matters for how you should think about it.
TelosRX works with partner compounding pharmacies that prepare compounded semaglutide and compounded tirzepatide. These are the same active molecules used in the brand-name products, prepared under separate compounding regulations rather than the standard new-drug approval pathway.
Any prescription is subject to medical approval by a licensed provider, based on your health history and the intake you complete. Nothing here is automatic, and nothing is guaranteed before that review happens.
Key takeaway: Switching after a denial means choosing a different, cash-pay compounded option, not obtaining the denied brand-name drug through another route. Being clear about that distinction is part of making an informed choice.
Comparing the two paths honestly
A brand-name GLP-1 with insurance approval, when it happens, can end up costing less out of pocket than a cash-pay option, depending on your specific plan design and deductible. That is worth acknowledging rather than glossing over.
The tradeoff is timing and certainty. A pending prior authorization or appeal has no fixed timeline and no guaranteed outcome. Compounded treatment through telos rx has a known monthly price and no insurance decision standing between you and starting. Compounded semaglutide starts as low as $99 a month, and compounded tirzepatide starts as low as $139 a month.
Some people run both paths at once. They start compounded treatment now and keep an insurance appeal open in the background, switching later if the appeal succeeds and a brand-name option becomes affordable through their plan.
What the intake process looks like
Intake at telos rx is asynchronous, meaning you complete a written online visit rather than booking a live video appointment. You answer questions about your health history, current medications, and goals, and a licensed provider reviews your submission on their own schedule.
If approved, your prescription is sent to a partner compounding pharmacy, and your medication ships directly to you. Most plans include shipping, and many people receive their first shipment within a matter of days of approval.
Your plan typically includes ongoing check-ins, dose adjustments, and periodic labs, so switching to compounded treatment is not a one-time transaction. It is meant to function as ongoing care, with a provider available to message as questions come up.
You can complete the whole intake from a phone or a laptop, at whatever time of day suits you. Begin your online visit whenever you are ready to see whether you qualify.
What to have ready before you start
Gathering a few details before you begin makes intake faster and more accurate. Know your current height and weight, any medications you take now, and any prior attempts at weight management, whether that was a different GLP-1, a diet program, or something else.
If you were previously prescribed a brand-name GLP-1 and stopped due to a denial, note roughly how long you were on it and at what dose. That history can be relevant to how a provider evaluates your intake. You do not need medical records on hand, only an honest account of your history.
Being thorough here matters more than being fast. A provider reviewing an incomplete picture is more likely to ask follow-up questions before approving anything, which adds time you could otherwise avoid.
Being honest about what insurance covers
No insurer, including Medicare or Medicaid, covers compounded medication. That is a well-established fact, not a technicality, and it is worth stating plainly rather than leaving it implied. If you are switching specifically to get insurance to pay, compounded treatment will not do that for you.
What compounded treatment does offer is a way to stop waiting on an insurance decision that may never come through. That is a different kind of value, and it is the honest reason most people make this switch.
See if compounded treatment is right for you before deciding whether to keep appealing your denial.
Using FSA or HSA funds to offset the cost
TelosRX plans are FSA and HSA eligible, so pretax dollars already set aside for medical expenses can typically be applied to compounded treatment. This is separate from the insurance question entirely, since FSA and HSA eligibility depends on your plan's rules for qualified medical expenses, not on whether a specific medication carries insurance coverage.
If you had funds earmarked for a brand-name prescription that never got approved, redirecting them toward a compounded option is often possible, though you should confirm your specific administrator's documentation requirements first.
If the injection itself is a barrier
Some people switching after a denial also want to switch formats. A needle-free oral GLP-1 is available from $9 a day, offering oral semaglutide or oral tirzepatide depending on what a clinician determines fits your history.
A lower-dose microdosed tirzepatide protocol is also available, as low as $116 a month, for people who want a gentler introduction to this medication class. Both remain subject to medical approval by a licensed provider, the same as any other option here.
What to watch for after you switch
Give your body a few weeks to adjust before judging whether compounded treatment is working for you. Digestive side effects in the first weeks are common with this medication class generally, whether the source is brand-name or compounded, and they tend to ease as your dose stabilizes.
Keep your provider updated through the messaging system rather than guessing on your own about dose changes. Your plan includes access to a licensed provider for exactly this reason, and adjustments should be made with their input, not on your own timeline.
Questions to ask yourself before switching
Ask whether your denial is truly final or whether an appeal is genuinely likely to change the outcome. A plan-level exclusion for weight-loss drugs rarely reverses on appeal, while a documentation gap sometimes does.
Ask what the ongoing wait is actually costing you, in health, time, or stress, not just in dollars. A slow process that never resolves is its own kind of cost, even before you look at price.
Ask whether a fixed, known monthly price is worth more to you right now than the possibility of a lower cost later if an appeal eventually succeeds. There is no universally correct answer, only the one that fits your situation.
Frequently Asked Questions
Is compounded GLP-1 medication the same drug as the brand-name product?
No. It uses the same active molecule but is prepared by a licensed compounding pharmacy rather than manufactured as an FDA-approved product. It is a distinct, different option, not the denied brand-name drug obtained another way.
Will switching to compounded treatment get my insurance to cover it?
No. Insurance, Medicare, and Medicaid do not cover compounded medication. Compounded treatment through telos rx is a cash-pay option, separate from any insurance decision about a brand-name product.
How fast can I start after switching?
Many people complete intake and receive a decision within a day or two, since review is asynchronous rather than dependent on a scheduled appointment. Shipping timelines vary but are typically a matter of days after approval.
Can I switch back to the brand-name drug later if my appeal succeeds?
Yes, that decision is yours to make with your provider at that time. Many people run both paths at once, using compounded treatment now while an appeal continues in the background.
Can I use FSA or HSA funds for compounded treatment?
Yes, telos rx plans are FSA and HSA eligible, so pretax funds can generally be applied toward the monthly cost. Confirm your plan's specific documentation requirements with your administrator.
Is a prescription guaranteed once I complete intake?
No. Every prescription is subject to medical approval by a licensed provider based on your health history and the information in your intake. Approval is not automatic for anyone.
TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. For general background on this medication class, see the NIH NIDDK overview of prescription weight-management medication. For how compounded medication is regulated, see the FDA overview of drug compounding.
Ready to stop waiting? Message the TelosRX care team or start your evaluation at TelosRX.